Rockefeller Capital Management L.P. - BENITEC BIOPHARMA INC ownership

BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 15 filers reported holding BENITEC BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of BENITEC BIOPHARMA INC
ValueSharesWeighting
Q4 2022$03000.0%0.00%
Q3 2022$03000.0%0.00%
Q2 2022$03000.0%0.00%
Q1 2022$03000.0%0.00%
Q4 2021$0
-100.0%
3000.0%0.00%
Q3 2021$1,0000.0%3000.0%0.00%
Q2 2021$1,0000.0%3000.0%0.00%
Q1 2021$1,0003000.0%0.00%
Q4 2020$0
-100.0%
3000.0%0.00%
Q3 2020$1,0003000.00%
Other shareholders
BENITEC BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
SUVRETTA CAPITAL MANAGEMENT, LLC 769,000$161,4130.01%
Virtu Financial LLC 121,514$260.00%
WealthTrust Axiom LLC 12,950$2,7180.00%
FRANKLIN RESOURCES INC 10,000,000$2,099,0000.00%
Walleye Capital LLC 215,989$45,3360.00%
UBS Group AG 347$730.00%
TWO SIGMA INVESTMENTS, LP 26,747$5,6140.00%
WELLS FARGO & COMPANY/MN 193$410.00%
NORTHERN TRUST CORP 11,813$2,4800.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BENITEC BIOPHARMA INC shareholders